- US12618072utility2026Methods of Treatment of Scn2a-related Disorders0 cites
- US12583849utility2026KCNT1 Inhibitors and Methods of Use0 cites
- US12528772utility2026Formulations of T-type Calcium Channel Modulators and Methods of Use Thereof0 cites
- US12479844utility2025Ion Channel Modulators0 cites
- US12404297utility2025Salts and Crystal Forms of GABA- a Positive Allosteric Modulator0 cites
- US12344615utility2025Substituted Pyridines as Ion Channel Modulators0 cites
- US12259378utility2025Dynamic Clamps and Methods of Use Thereof0 cites
- US12145939utility2024Substituted [1,2,4]triazolo[4,3-a]pyrazines as Ion Channel Modulators0 cites
- US12077502utility2024Formulations of T-type Calcium Channel Modulators and Methods of Use Thereof0 cites
- US12049448utility2024Formulations of T-type Calcium Channel Modulators and Methods of Use Thereof0 cites
- US12030881utility2024Ion Channel Modulators0 cites
- US11918571utility2024Compounds and Their Methods of Use0 cites
- US11866439utility2024Ion Channel Modulators0 cites
- US11773088utility2023KCNT1 Inhibitors and Methods of Use0 cites
- US11773099utility2023Compounds and Their Methods of Use0 cites
- US11767325utility2023Substituted [1,2,4]triazolo[4,3-a]pyrazines as Ion Channel Modulators0 cites
- US11731966utility2023Compounds and Their Methods of Use0 cites
Page 1 of 2Next →